ZYUS LIFE SCIENCES CORP (ZYUS.CA) Stock News

Canada - TSX-V:ZYUS - CA9899601095 - Common Stock

0.7 CAD

0 (0%)

Last: 11/10/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ZYUS.CA Latest News, Press Relases and Analysis

All

Press Releases

6 months ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

2 years ago - By: Benzinga - Mentions: BGXX BMY HMPG.CA CL ...

Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

2 years ago - By: ZYUS Life Sciences Corp. - Mentions: TSX

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

2 years ago - By: ZYUS Life Sciences Corporation - Mentions: TSX

ZYUS Life Sciences Announces Final Approval to Commence Trading on June 19, 2023, and Engages Independent Trading Group (“ITG”) as Market Maker